|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0007131,
umls-concept:C0008976,
umls-concept:C0013216,
umls-concept:C0034656,
umls-concept:C0162458,
umls-concept:C0205179,
umls-concept:C0205195,
umls-concept:C0337810,
umls-concept:C0439743,
umls-concept:C0684224,
umls-concept:C0684249
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1993-12-6
|
|
pubmed:abstractText |
Preclinical data suggested that alpha-interferon (IFN) may potentiate chemotherapy cytotoxicity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
72
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
2929-35
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8221559-Aged,
pubmed-meshheading:8221559-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8221559-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:8221559-Cisplatin,
pubmed-meshheading:8221559-Combined Modality Therapy,
pubmed-meshheading:8221559-Cyclophosphamide,
pubmed-meshheading:8221559-Epirubicin,
pubmed-meshheading:8221559-Female,
pubmed-meshheading:8221559-Humans,
pubmed-meshheading:8221559-Interferon-alpha,
pubmed-meshheading:8221559-Italy,
pubmed-meshheading:8221559-Leukopenia,
pubmed-meshheading:8221559-Lung Neoplasms,
pubmed-meshheading:8221559-Male,
pubmed-meshheading:8221559-Middle Aged,
pubmed-meshheading:8221559-Prospective Studies,
pubmed-meshheading:8221559-Recombinant Proteins,
pubmed-meshheading:8221559-Remission Induction,
pubmed-meshheading:8221559-Survival Rate,
pubmed-meshheading:8221559-Thrombocytopenia
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force.
|
|
pubmed:affiliation |
Instituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
